KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Other financing activities (2016)

Historic Other financing activities for Novavax (NVAX) over the last 8 years, with Q1 2016 value amounting to $10.0 million.

  • Novavax's Other financing activities changed N/A to $10.0 million in Q1 2016 from the same period last year, while for Dec 2016 it was $10.0 million, marking a year-over-year increase of 800952.38%. This contributed to the annual value of $10.0 million for FY2016, which is 800952.38% up from last year.
  • Latest data reveals that Novavax reported Other financing activities of $10.0 million as of Q1 2016.
  • In the past 5 years, Novavax's Other financing activities registered a high of $10.0 million during Q1 2016, and its lowest value of -$755000.0 during Q1 2012.
  • Moreover, its 5-year median value for Other financing activities was -$1000.0 (2012), whereas its average is $1.3 million.
  • As far as peak fluctuations go, Novavax's Other financing activities tumbled by 15580.19% in 2012, and later surged by 9986.75% in 2013.
  • Quarter analysis of 5 years shows Novavax's Other financing activities stood at -$1000.0 in 2012, then changed by 0.0% to -$1000.0 in 2013, then changed by 0.0% to -$1000.0 in 2014, then plummeted by 12500.0% to -$126000.0 in 2015, then surged by 8009.52% to $10.0 million in 2016.
  • Its Other financing activities stands at $10.0 million for Q1 2016, versus -$126000.0 for Q3 2015 and -$1000.0 for Q4 2014.